Afternoon flu concept shows partial fluctuations, Hualan Vac rises over 10%Zhitong·Nov 3, 2025 at 11:44 PM002007-0.30%301207+1.67%
Overview of A-share dividends and stock distributions: 9 stocks have their equity registration todayZhitong·Oct 23, 2025 at 06:54 PM002007-0.30%301207+1.67%
The flu vaccine has a "freezing point price" of 5.5 yuan36Kr·Sep 3, 2025 at 10:21 PM002007-0.30%002581+3.64%
HUALAN BIOLOGICAL released its performance for the first half of the year, with a net profit attributable to the parent company of 516 million yuan, a year-on-year increase of 17.19%Zhitong·Aug 27, 2025 at 06:31 AM002007-0.30%
HUALAN BIOLOGICAL's subsidiary genetic engineering company increased its capital to 300 million, an increase of 50%Zhitong·Aug 21, 2025 at 02:57 AM002007-0.30%
Zhonghui Biological: Holding high-end vaccine single product performance surges, yet still struggling to break the industry's involution dilemma?Zhitong·Jul 28, 2025 at 12:28 AM002007-0.30%688185+1.43%
HUALAN BIOLOGICAL plans to increase its investment in its affiliated company HUALAN GENETICS by 200 million yuanZhitong·Jul 8, 2025 at 06:09 AM002007-0.30%
HUALAN BIOLOGICAL and others established an international trading company in ShanghaiZhitong·Jul 3, 2025 at 09:53 PM002007-0.30%
HUALAN BIOLOGICAL's trivalent influenza vaccine loses World Health Organization prequalification statusZhitong·Jul 1, 2025 at 09:51 PM002007-0.30%
HUALAN BIOLOGICAL released its first-quarter performance, with a net profit attributable to the parent company of 313 million yuan, a year-on-year increase of 19.62%Zhitong·Apr 27, 2025 at 05:42 AM002007-0.30%
Overview of A-share Stock Buybacks: Today, 88 Companies Disclosed Buyback ProgressZhitong·Apr 25, 2025 at 07:26 PM688186+2.82%600019-2.08%
HUALAN BIOLOGICAL released its 2024 annual performance, with a net profit attributable to the parent company of 1.088 billion yuan, a year-on-year decrease of 26.57%Zhitong·Mar 28, 2025 at 04:28 AM002007-0.30%
